Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.

Spectrum: Partisan Bill (Republican 9-0)

Status: (Introduced - Dead) 2017-04-04 - Action deferred to first calendar of 2018 [SB0922 Detail]

Text: Latest bill text (Draft #1) [PDF]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
No roll call record information currently on file.

States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on TN SB0922